UTAH MEDICAL PRODUCTS INC
About UTAH MEDICAL PRODUCTS INC
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $38.5M
- Total assets
- $122.5M
- Market cap
- $215.4M
- Gross margin
- 57.1%
- Operating margin
- 29.6%
- Net margin
- 29.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $38.5M
- Cost of revenue
- $16.5M
- Gross profit
- $22.0M
- Operating expenses
- $10.6M
- Operating income
- $11.4M
- Income tax
- $2.8M
- Net income
- $11.3M
- EPS (basic)
- $3.48
- EPS (diluted)
- $3.48
Balance sheet
- Total assets
- $122.5M
- Current assets
- $97.7M
- Total liabilities
- $3.3M
- Current liabilities
- $2.6M
- Shareholders’ equity
- $119.3M
Cash flow
- Operating cash flow
- $14.7M
- Investing cash flow
- -$371.0K
- Financing cash flow
- -$12.3M
- Net cash flow
- $2.8M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $215.4M
- P/E ratio
- 19.3
- EPS (diluted)
- $3.48
- Dividend yield
- 1.85%
- Shares outstanding
- 3.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 1, 1982
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Revenue declined 21% from FY2021 to FY2025.
- Gross margin of 57.1%, net margin 29.3%.
- Trading 5% below its 52-week high.
- Pays a dividend yielding about 1.85% annually.
- Valued at a price-to-earnings (P/E) ratio of 19.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review UTAH MEDICAL PRODUCTS INC.
Write a review
News about UTAH MEDICAL PRODUCTS INC
News & sentiment via Polygon.io
